A genetic and proteomic comparison of key AD biomarkers across tissues is a research paper published in Alzheimer s & Dementia (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01AG044546
National Institutes of Health
Grant: P30AG066444
National Institutes of Health
Grant: P01AG003991
National Institutes of Health
Grant: P01AG026276
National Institutes of Health
Grant: RF1AG053303
National Institutes of Health
Grant: RF1AG058501
National Institutes of Health
Grant: U01AG058922
National Institutes of Health
Grant: RF1AG074007
National Institutes of Health
Grant: R00AG062723
National Institutes of Health
Grant: P30 AG066515
U.S. Department of Defense
Grant: LI‐ W81XWH2010849
GlaxoSmithKline
Grant: P01AG03991
Alzheimer's Association
Grant: SG‐20‐690363
Alzheimer's Disease Neuroimaging Initiative
Grant: U01 AG024904
Alzheimer's Disease Neuroimaging Initiative
Grant: W81XWH‐12‐2‐0012
European Commission
Grant: 860197
Multi-omics Interdisciplinary Research Integration to Address DEmentia diagnosis
European Commission
Grant: 831434
Identification of the Molecular Mechanisms of non-response to Treatments, Relapses and Remission in Autoimmune, Inflammatory, and Allergic Conditions
Selfridges Group Foundation
Grant: NR170065
National Institutes of Health
Grant: 5P01AG003991-38
Healthy Aging and Senile Dementia
National Institutes of Health
Grant: 3RF1AG053303-01S1
USING QUANTITATIVE TRAITS TO IDENTIFY NOVEL GENES FOR ALZHEIMERS DISEASE AND OTHER COMPLEX TRAITS
National Institutes of Health
Grant: 1U01AG024904-01
Alzheimers Disease Neuroimaging Initiative
National Institutes of Health
Grant: 5U19AG032438-03
DIAN Genetics Core
National Institutes of Health
Grant: 5P30AG066515-03
Stanford Alzheimer's Disease Research Center
European Commission
Grant: 101034344
European platform for neurodegenerative disorders
National Institutes of Health
Grant: 1P30AG066444-01
Alzheimer's Disease Research Center
National Institutes of Health
Grant: 5R01AG044546-03
IDENTIFYING RARE VARIANTS THAT INCREASE RISK FOR ALZHEIMER'S DISEASE
National Institutes of Health
Grant: 1RF1AG074007-01
Sex-specific Molecular Profiling to Understand Pathology and Identify Causal Genes and Drug Targets for Alzheimer's Disease
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P01AG026276-07
Antecedent Neuroimaging Biomarkers
National Institutes of Health
Grant: 5R00AG062723-05
Plasma Cell-Free RNA as Non-invasive Biomarker for Neurodegeneration
National Institutes of Health
Grant: 5U01AG058922-05
The Familial Alzheimer Sequencing (FASe) Project
National Institutes of Health
Grant: 1RF1AG058501-01
GENETIC MODIFIERS OF CEREBROSPINAL FLUID TREM2 IN ALZHEIMER'S DISEASE
ZonMw
Grant: 73305095007
Department of Defense
Grant: LI- W81XWH2010849
Alzheimer's Disease Neuroimaging Initiative
Grant: W81XWH-12-2-0012
Topsector Life Sciences & Health
Grant: LSHM20106
Ministerio Español de Ciencia e innovación
Grant: PID2020-115613RA-I00
Comunidad de Maddrid
Grant: 2018-T2/BMD-14885
Bright Focus Foundation
Grant: A2021033S
Alzheimer's Association Zenith Fellows Award
Grant: ZEN-22-848604
Dominantly Inherited Alzheimer Network
Grant: U19AG032438
Alzheimer's Association
Grant: SG-20-690363
Araclon Biotech
NIBIB NIH HHS
Fonds de Recherche du Québec Santé
Health∼Holland
Alzheimer Nederland
EuroImmun
Biogen
Michael J. Fox Foundation
Gieskes-Strijbisfonds
Servier
Lumosity
Bristol-Myers Squibb Company
Janssen Alzheimer Immunotherapy Research and Development, LLC
Piramal Imaging
Merck & Co. Inc.
Novartis Pharmaceuticals Corporation
GE Healthcare
Brain Canada Foundation
Elan Pharmaceuticals Inc.
AbbVie
Johnson & Johnson Pharmaceutical Research and Development, LLC.
Transition Therapeutics
F. Hoffman-La Roche Ltd
Takeda Pharmaceutical Compant
Alzheimer Drug Discovery Foundation
WashU Departments of Neurology and Psychiatry
Pfizer Inc.
Chan Zuckerberg Initiative
Eli Lilly and Company
CereSpir Inc.
IXICO Ltd.
NeuroRx Research
BioClinica Inc.
Meso Scale Diagnostics LLC
Neurotrack Technologies
Fujirebio
Lundbeck
Genentech Inc.
Eisai Inc.
FWCI
0.00
Citation Percentile
0.0%
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals